AI-generated summary
The authors compared growth hormone release after a baclofen challenge, an index of hypothalamic GABAB receptor function, in 15 patients with seasonal affective disorder and 20 matched healthy controls. Baclofen raised growth hormone in both groups with no significant group difference, and 2-week light therapy did not significantly change the response in patients. The study was small and the authors report no change in receptor function.
- Who or what was studied
- 15 patients with seasonal affective disorder and 20 matched healthy controls; 14 patients had repeat challenge after 2 weeks of light therapy
- Limits stated in the abstract
- The sample is small and the abstract does not state a wavelength for the light therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.